[Survey of susceptibility of methicillin-resistant Staphylococcus aureus to antimicrobial agents in Hokusetsu General Hospital].
We examined the annual isolation rate, susceptibility to antimicrobial agents and coagulase types of methicillin-resistant Staphylococcus aureus (MRSA) isolated from inpatients in Hokusetsu General Hospital to ascertain the situation of MRSA isolates between 1992 and 2001. The isolation rate of MRSA in S. aureus increased annually from 1992, reaching 65.3% in 2001. The isolation rates of MRSA in the inpatients were 3.2 times greater than those in the outpatients. In the clinical specimens the isolation rate of MRSA from sputum was the highest, i.e., 32.9%. In respect of the coagulase types, type II accounted for 85.7% of the all types. MIC90 values of arbekacin, sulfmethoxazole-trimethoprin, vancomycin, teicopranin and minocycline were 4.0, 2.0, 2.0, 2.0, and 8.0 micrograms/ml, respectively.
Hijioka
Sumiko
S
Department of Clinical Laboratory, Hokusetsu General Hospital.
Nakata
Ryoko
R
Yoshinami
Yuko
Y
Sugita
Kumiko
K
Nishimura
Tadafumi
T
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D003030:Coagulase; D003982:Dibekacin / Q000031:analogs & derivatives* / Q000494:pharmacology; D024881:Drug Resistance, Bacterial; D006769:Hospitals, General; D007564:Japan; D016106:Methicillin Resistance; D008911:Minocycline / Q000494:pharmacology; D012703:Serotyping; D013211:Staphylococcus aureus / Q000145:classification / Q000187:drug effects* / Q000302:isolation & purification*; D017334:Teicoplanin / Q000494:pharmacology; D013997:Time Factors; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000494:pharmacology; D014640:Vancomycin / Q000494:pharmacology
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D003030:Coagulase; D003982:Dibekacin; D017334:Teicoplanin; D014640:Vancomycin; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D008911:Minocycline; C031986:arbekacin